ETopical – Lifestyle
Home
Sample Page
Author:
Galimedix Therapeutics, Inc.
Galimedix Therapeutics to present promising pre-clinical data with next generation oral amyloid beta aggregation modulator at AD/PD™ 2026 Conference
March 5, 2026